• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

ProCertus BioPharm

edit

ProCertus BioPharm, Inc., an oncology-based pharmaceutical company, develops therapeutics to protect cancer patients from the side effects of radiotherapy and chemotherapy in the United States. Its products include ProDermaCel that protects cancer patients from chemotherapy- and radiotherapy-induced alopecia; DermX, which prevents radiotherapy-induced dermatitis; and OralX that provides protection against chemotherapy- and radiotherapy- induced oral mucositis. ProCertus BioPharm, Inc. was founded in 1997 and is based in Madison, Wisconsin.

Milestones

edit

• 
  ProCertus BioPharm added William E. Fahl as Chairman, and Chief Scientific Officer.
  Posted 4/5/11 at 6:28pm
• 
  ProCertus BioPharm added Paul M. Weiss as President and CEO.
  Posted 4/5/11 at 6:28pm
• 
  ProCertus BioPharm received $1.7M in Series A funding. (4/5/11)
  Posted 4/5/11 at 6:28pm via procertus.com

Videos

Screenshots

edit

Sources

1. ProCertus BioPharm secures $1.7 million in financing (procertus.com) [edit]